{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:50:00Z","timestamp":1793742600024,"version":"4.6.1"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:00:00Z","timestamp":1770422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"DOI":"10.1007\/s12026-026-09747-5","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:47:27Z","timestamp":1770450447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Shifts in immunometabolism in autoimmune diseases"],"prefix":"10.1007","volume":"74","author":[{"given":"Sadichha Sanjay","family":"Mantri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8490-0705","authenticated-orcid":false,"given":"Gaurav Mahesh","family":"Doshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,7]]},"reference":[{"key":"9747_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.789","author":"R Xu","year":"2024","unstructured":"Xu R, He X, Xu J, Yu G, Wu Y. Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. MedComm. 2024. https:\/\/doi.org\/10.1002\/mco2.789.","journal-title":"MedComm"},{"key":"9747_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1285720","author":"F Zheng","year":"2023","unstructured":"Zheng F, Raes G, Lu S, Chen Q. Editorial: immunometabolism in autoimmune and autoinflammatory disorders. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1285720.","journal-title":"Front Immunol"},{"key":"9747_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000521305","volume":"14","author":"T Chavakis","year":"2022","unstructured":"Chavakis T. Immunometabolism: where immunology and metabolism meet. J Innate Immun. 2022;14:1\u20133. https:\/\/doi.org\/10.1159\/000521305.","journal-title":"J Innate Immun"},{"key":"9747_CR4","unstructured":"Ghanouni M. The Role of Immunometabolism in Disease. Development Engineering Conferences Center Articles database, 2024. http:\/\/chemistry.bcnf.ir"},{"key":"9747_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41423-022-00840-x","volume":"19","author":"H Chi","year":"2022","unstructured":"Chi H. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology. Cell Mol Immunol. 2022;19:299\u2013302. https:\/\/doi.org\/10.1038\/s41423-022-00840-x.","journal-title":"Cell Mol Immunol"},{"key":"9747_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01954-6","volume":"9","author":"T Hu","year":"2024","unstructured":"Hu T, Liu C-H, Lei M, Zeng Q, Li L, Tang H, et al. Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. Signal Transduct Target Ther. 2024;9:268. https:\/\/doi.org\/10.1038\/s41392-024-01954-6.","journal-title":"Signal Transduct Target Ther"},{"key":"9747_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002084","volume":"21","author":"LP Blanco","year":"2023","unstructured":"Blanco LP, Kaplan MJ. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases. PLoS Biol. 2023;21:e3002084. https:\/\/doi.org\/10.1371\/journal.pbio.3002084.","journal-title":"PLoS Biol"},{"key":"9747_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.969939","author":"V Pucino","year":"2022","unstructured":"Pucino V, Guma M. Editorial: the role of immunometabolism in autoimmune mediated and autoinflammatory disorders. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.969939.","journal-title":"Front Immunol"},{"key":"9747_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20236008","volume":"20","author":"S Kany","year":"2019","unstructured":"Kany S, Vollrath JT, Relja B. Cytokines in inflammatory disease. Int J Mol Sci. 2019;20:6008. https:\/\/doi.org\/10.3390\/ijms20236008.","journal-title":"Int J Mol Sci"},{"key":"9747_CR10","doi-asserted-by":"publisher","unstructured":"Hortov\u00e1-Kohoutkov\u00e1 M, L\u00e1zni\u010dkov\u00e1 P, Fri\u010d J How immune\u2010cell fate and function are determined by metabolic pathway choice. BioEssays. 2021;43. https:\/\/doi.org\/10.1002\/bies.202000067.","DOI":"10.1002\/bies.202000067"},{"key":"9747_CR11","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16:553\u201365. https:\/\/doi.org\/10.1038\/nri.2016.70.","journal-title":"Nat Rev Immunol"},{"key":"9747_CR12","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1111\/bph.12394","volume":"171","author":"RH Swerdlow","year":"2014","unstructured":"Swerdlow RH. Bioenergetic medicine. Br J Pharmacol. 2014;171:1854\u201369. https:\/\/doi.org\/10.1111\/bph.12394.","journal-title":"Br J Pharmacol"},{"key":"9747_CR13","unstructured":"Nicholls David G. Bioenergetics [Internet]. 4th ed. Academic Press, 2013. Paperback ISBN: 9780123884251."},{"key":"9747_CR14","volume-title":"Biochemistry","author":"JM Berg","year":"2024","unstructured":"Berg JM, Gatto GJ, Hines JK, Tymoczko JL. Biochemistry. tenth. Macmillan learning; 2024.","edition":"tenth"},{"key":"9747_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-015-0390-6","volume":"14","author":"KY Hara","year":"2015","unstructured":"Hara KY, Kondo A. ATP regulation in bioproduction. Microb Cell Fact. 2015;14:198. https:\/\/doi.org\/10.1186\/s12934-015-0390-6.","journal-title":"Microb Cell Fact"},{"key":"9747_CR16","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","volume":"8","author":"M Bonora","year":"2012","unstructured":"Bonora M, Patergnani S, Rimessi A, De Marchi E, Suski JM, Bononi A, et al. ATP synthesis and storage. Purinergic Signal. 2012;8:343\u201357. https:\/\/doi.org\/10.1007\/s11302-012-9305-8.","journal-title":"Purinergic Signal"},{"key":"9747_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02141-x","volume":"10","author":"H Liu","year":"2025","unstructured":"Liu H, Wang S, Wang J, Guo X, Song Y, Fu K, et al. Energy metabolism in health and diseases. Signal Transduct Target Ther. 2025;10:69. https:\/\/doi.org\/10.1038\/s41392-025-02141-x.","journal-title":"Signal Transduct Target Ther"},{"key":"9747_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040535","volume":"13","author":"NS Chandel","year":"2021","unstructured":"Chandel NS. Glycolysis. Cold Spring Harb Perspect Biol. 2021;13:a040535. https:\/\/doi.org\/10.1101\/cshperspect.a040535.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9747_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2020.148276","volume":"1861","author":"M Rigoulet","year":"2020","unstructured":"Rigoulet M, Bouchez CL, Paumard P, Ransac S, Cuvellier S, Duvezin-Caubet S, et al. Cell energy metabolism: an update. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2020;1861:148276. https:\/\/doi.org\/10.1016\/j.bbabio.2020.148276.","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"9747_CR20","doi-asserted-by":"publisher","unstructured":"TeSlaa T, Teitell MA. Techniques to Monitor Glycolysis. 2014. pp. 91\u2013114. https:\/\/doi.org\/10.1016\/B978-0-12-416618-9.00005-4","DOI":"10.1016\/B978-0-12-416618-9.00005-4"},{"key":"9747_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.copbio.2020.09.014","volume":"68","author":"DG Ryan","year":"2021","unstructured":"Ryan DG, Frezza C, O\u2019Neill LA. TCA cycle signalling and the evolution of eukaryotes. Curr Opin Biotechnol. 2021;68:72\u201388. https:\/\/doi.org\/10.1016\/j.copbio.2020.09.014.","journal-title":"Curr Opin Biotechnol"},{"key":"9747_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes I, Chandel NS. Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun. 2020;11:102. https:\/\/doi.org\/10.1038\/s41467-019-13668-3.","journal-title":"Nat Commun"},{"key":"9747_CR23","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.bbamcr.2007.10.001","volume":"1773","author":"M H\u00fcttemann","year":"2007","unstructured":"H\u00fcttemann M, Lee I, Samavati L, Yu H, Doan JW. Regulation of mitochondrial oxidative phosphorylation through cell signaling. Biochim Et Biophys Acta (BBA) - Mol Cell Res. 2007;1773:1701\u201320. https:\/\/doi.org\/10.1016\/j.bbamcr.2007.10.001.","journal-title":"Biochim Et Biophys Acta (BBA) - Mol Cell Res"},{"key":"9747_CR24","doi-asserted-by":"publisher","first-page":"7023","DOI":"10.1113\/JP273839","volume":"595","author":"DF Wilson","year":"2017","unstructured":"Wilson DF. Oxidative phosphorylation: regulation and role in cellular and tissue metabolism. J Physiol. 2017;595:7023\u201338. https:\/\/doi.org\/10.1113\/JP273839.","journal-title":"J Physiol"},{"key":"9747_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbabio.2013.10.004","volume":"1837","author":"Y Chaban","year":"2014","unstructured":"Chaban Y, Boekema EJ, Dudkina NV. Structures of mitochondrial oxidative phosphorylation supercomplexes and mechanisms for their stabilisation. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2014;1837:418\u201326. https:\/\/doi.org\/10.1016\/j.bbabio.2013.10.004.","journal-title":"Biochimica et Biophysica Acta (BBA) - Bioenergetics"},{"key":"9747_CR26","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.mito.2020.10.004","volume":"58","author":"B Kadenbach","year":"2021","unstructured":"Kadenbach B. Complex IV \u2013 the regulatory center of mitochondrial oxidative phosphorylation. Mitochondrion. 2021;58:296\u2013302. https:\/\/doi.org\/10.1016\/j.mito.2020.10.004.","journal-title":"Mitochondrion"},{"key":"9747_CR27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.920029","author":"Y Xu","year":"2022","unstructured":"Xu Y, Chen Y, Zhang X, Ma J, Liu Y, Cui L, et al. Glycolysis in innate immune cells contributes to autoimmunity. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.920029.","journal-title":"Front Immunol"},{"key":"9747_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/life11010069","volume":"11","author":"I Choi","year":"2021","unstructured":"Choi I, Son H, Baek J-H. Tricarboxylic acid (TCA) cycle intermediates: regulators of immune responses. Life. 2021;11:69. https:\/\/doi.org\/10.3390\/life11010069.","journal-title":"Life"},{"key":"9747_CR29","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s41423-020-0465-0","volume":"17","author":"KL Hilligan","year":"2020","unstructured":"Hilligan KL, Ronchese F. Antigen presentation by dendritic cells and their instruction of CD4\u2009+\u2009T helper cell responses. Cell Mol Immunol. 2020;17:587\u201399. https:\/\/doi.org\/10.1038\/s41423-020-0465-0.","journal-title":"Cell Mol Immunol"},{"key":"9747_CR30","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.619195","author":"Z Wang","year":"2021","unstructured":"Wang Z, Guan D, Huo J, Biswas SK, Huang Y, Yang Y, et al. IL-10 enhances human natural killer cell effector functions via metabolic reprogramming regulated by mTORC1 signaling. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.619195.","journal-title":"Front Immunol"},{"key":"9747_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/7483865","volume":"2021","author":"S Sun","year":"2021","unstructured":"Sun S, Gu Y, Wang J, Chen C, Han S, Che H. Effects of fatty acid oxidation and its regulation on dendritic cell-mediated immune responses in allergies: an immunometabolism perspective. J Immunol Res. 2021;2021:1\u201310. https:\/\/doi.org\/10.1155\/2021\/7483865.","journal-title":"J Immunol Res"},{"key":"9747_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.986847","author":"X Feng","year":"2022","unstructured":"Feng X, Li X, Liu N, Hou N, Sun X, Liu Y. Glutaminolysis and CD4\u2009+\u2009T-cell metabolism in autoimmunity: from pathogenesis to therapy prospects. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.986847.","journal-title":"Front Immunol"},{"key":"9747_CR33","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/brv.12140","volume":"90","author":"A Stincone","year":"2015","unstructured":"Stincone A, Prigione A, Cramer T, Wamelink MMC, Campbell K, Cheung E, et al. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev. 2015;90:927\u201363. https:\/\/doi.org\/10.1111\/brv.12140.","journal-title":"Biol Rev"},{"key":"9747_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202004433","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: from clinical significance to quantification. Adv Sci. 2021. https:\/\/doi.org\/10.1002\/advs.202004433.","journal-title":"Adv Sci"},{"key":"9747_CR35","doi-asserted-by":"publisher","first-page":"9783","DOI":"10.1007\/s11033-022-07474-2","volume":"49","author":"C Hu","year":"2022","unstructured":"Hu C, Xuan Y, Zhang X, Liu Y, Yang S, Yang K. Immune cell metabolism and metabolic reprogramming. Mol Biol Rep. 2022;49:9783\u201395. https:\/\/doi.org\/10.1007\/s11033-022-07474-2.","journal-title":"Mol Biol Rep"},{"key":"9747_CR36","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1002\/cbin.11867","volume":"46","author":"S Chakraborty","year":"2022","unstructured":"Chakraborty S, Khamaru P, Bhattacharyya A. Regulation of immune cell metabolism in health and disease: special focus on T and B cell subsets. Cell Biol Int. 2022;46:1729\u201346. https:\/\/doi.org\/10.1002\/cbin.11867.","journal-title":"Cell Biol Int"},{"key":"9747_CR37","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/cei\/uxab021","volume":"208","author":"MM Hanlon","year":"2022","unstructured":"Hanlon MM, Canavan M, Barker BE, Fearon U. Metabolites as drivers and targets in rheumatoid arthritis. Clin Exp Immunol. 2022;208:167\u201380. https:\/\/doi.org\/10.1093\/cei\/uxab021.","journal-title":"Clin Exp Immunol"},{"key":"9747_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2025.101615","volume":"38","author":"TR Spitzer","year":"2025","unstructured":"Spitzer TR, Lazarus HM. Endogenous and exogenous cytokines: an overview and introduction. Best Pract Res Clin Haematol. 2025;38:101615. https:\/\/doi.org\/10.1016\/j.beha.2025.101615.","journal-title":"Best Pract Res Clin Haematol"},{"key":"9747_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1213448","author":"N Gonzalez Caldito","year":"2023","unstructured":"Gonzalez Caldito N. Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1213448.","journal-title":"Front Immunol"},{"key":"9747_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","volume":"22","author":"D Jang","year":"2021","unstructured":"Jang D, Lee A-H, Shin H-Y, Song H-R, Park J-H, Kang T-B, et al. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021;22:2719. https:\/\/doi.org\/10.3390\/ijms22052719.","journal-title":"Int J Mol Sci"},{"key":"9747_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255533","author":"E Grebenciucova","year":"2023","unstructured":"Grebenciucova E, VanHaerents S. Interleukin 6: at the interface of human health and disease. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1255533.","journal-title":"Front Immunol"},{"key":"9747_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109130","volume":"111","author":"M Aliyu","year":"2022","unstructured":"Aliyu M, Zohora FT, Anka AU, Ali K, Maleknia S, Saffarioun M, et al. Interleukin-6 cytokine: an overview of the immune regulation, immune dysregulation, and therapeutic approach. Int Immunopharmacol. 2022;111:109130. https:\/\/doi.org\/10.1016\/j.intimp.2022.109130.","journal-title":"Int Immunopharmacol"},{"key":"9747_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2023\/3360310","volume":"2023","author":"L Sun","year":"2023","unstructured":"Sun L, Wang L, Moore BB, Zhang S, Xiao P, Decker AM, et al. IL-17: balancing protective immunity and pathogenesis. J Immunol Res. 2023;2023:1\u20139. https:\/\/doi.org\/10.1155\/2023\/3360310.","journal-title":"J Immunol Res"},{"key":"9747_CR44","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2147\/ITT.S240891","volume":"10","author":"M Mosca","year":"2021","unstructured":"Mosca M, Hong J, Hadeler E, Hakimi M, Liao W, Bhutani T. The role of IL-17 cytokines in psoriasis. Immunotargets Ther. 2021;10:409\u201318. https:\/\/doi.org\/10.2147\/ITT.S240891.","journal-title":"Immunotargets Ther"},{"key":"9747_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113683","volume":"155","author":"H Ding","year":"2022","unstructured":"Ding H, Wang G, Yu Z, Sun H, Wang L. Role of interferon-gamma (IFN-\u03b3) and IFN-\u03b3 receptor 1\/2 (IFN\u03b3R1\/2) in regulation of immunity, infection, and cancer development: IFN-\u03b3-dependent or independent pathway. Biomed Pharmacother. 2022;155:113683. https:\/\/doi.org\/10.1016\/j.biopha.2022.113683.","journal-title":"Biomed Pharmacother"},{"key":"9747_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00312","author":"S Atiqi","year":"2020","unstructured":"Atiqi S, Hooijberg F, Loeff FC, Rispens T, Wolbink GJ. Immunogenicity of TNF-inhibitors. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.00312.","journal-title":"Front Immunol"},{"key":"9747_CR47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2016.08.014","volume":"101","author":"H Mitoma","year":"2018","unstructured":"Mitoma H, Horiuchi T, Tsukamoto H, Ueda N. Molecular mechanisms of action of anti-TNF-\u03b1 agents \u2013 comparison among therapeutic TNF-\u03b1 antagonists. Cytokine. 2018;101:56\u201363. https:\/\/doi.org\/10.1016\/j.cyto.2016.08.014.","journal-title":"Cytokine"},{"key":"9747_CR48","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1080\/21645515.2017.1316909","volume":"13","author":"M Sheppard","year":"2017","unstructured":"Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Hum Vaccin Immunother. 2017;13:1972\u201388. https:\/\/doi.org\/10.1080\/21645515.2017.1316909.","journal-title":"Hum Vaccin Immunother"},{"key":"9747_CR49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1470488","author":"S Parisi","year":"2025","unstructured":"Parisi S, Ditto MC, Ghellere F, Panaro S, Piccione F, Borrelli R, et al. Update on tocilizumab in rheumatoid arthritis: a narrative review. Front Immunol. 2025. https:\/\/doi.org\/10.3389\/fimmu.2025.1470488.","journal-title":"Front Immunol"},{"key":"9747_CR50","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1080\/14740338.2016.1221923","volume":"15","author":"A Blauvelt","year":"2016","unstructured":"Blauvelt A. Safety of secukinumab in the treatment of psoriasis. Expert Opin Drug Saf. 2016;15:1413\u201320. https:\/\/doi.org\/10.1080\/14740338.2016.1221923.","journal-title":"Expert Opin Drug Saf"},{"key":"9747_CR51","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","volume":"375","author":"BG Feagan","year":"2016","unstructured":"Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, et al. Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease. N Engl J Med. 2016;375:1946\u201360. https:\/\/doi.org\/10.1056\/NEJMoa1602773.","journal-title":"N Engl J Med"},{"key":"9747_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1626","author":"M Barberis","year":"2024","unstructured":"Barberis M, Rojas L\u00f3pez A. Metabolic imbalance driving immune cell phenotype switching in autoimmune disorders: tipping the balance of T- and B\u2010cell interactions. Clin Transl Med. 2024. https:\/\/doi.org\/10.1002\/ctm2.1626.","journal-title":"Clin Transl Med"},{"key":"9747_CR53","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/JIR.S398291","volume":"16","author":"T-T Luo","year":"2023","unstructured":"Luo T-T, Wu Y-J, Yin Q, Chen W-G, Zuo J. The involvement of glucose and lipid metabolism alteration in rheumatoid arthritis and its clinical implication. J Inflamm Res. 2023;16:1837\u201352. https:\/\/doi.org\/10.2147\/JIR.S398291.","journal-title":"J Inflamm Res"},{"key":"9747_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.652771","author":"J Qiu","year":"2021","unstructured":"Qiu J, Wu B, Goodman SB, Berry GJ, Goronzy JJ, Weyand CM. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.652771.","journal-title":"Front Immunol"},{"key":"9747_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112704","volume":"139","author":"L Yan","year":"2024","unstructured":"Yan L, Wang W, Qiu Y, Yu C, Wang R, Li C. Role of glucose metabolism reprogramming in keratinocytes in the link between psoriasis and metabolic syndrome. Int Immunopharmacol. 2024;139:112704. https:\/\/doi.org\/10.1016\/j.intimp.2024.112704.","journal-title":"Int Immunopharmacol"},{"key":"9747_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2023.1201912","author":"E Sarandi","year":"2023","unstructured":"Sarandi E, Krueger-Krasagakis S, Tsoukalas D, Sidiropoulou P, Evangelou G, Sifaki M, et al. Psoriasis immunometabolism: progress on metabolic biomarkers and targeted therapy. Front Mol Biosci. 2023. https:\/\/doi.org\/10.3389\/fmolb.2023.1201912.","journal-title":"Front Mol Biosci"},{"key":"9747_CR57","doi-asserted-by":"publisher","first-page":"302","DOI":"10.4049\/jimmunol.2300319","volume":"212","author":"B Dhamija","year":"2024","unstructured":"Dhamija B, Marathe S, Sawant V, Basu M, Attrish D, Mukherjee D, et al. IL-17A orchestrates reactive oxygen species\/HIF1\u03b1\u2013mediated metabolic reprogramming in psoriasis. J Immunol. 2024;212:302\u201316. https:\/\/doi.org\/10.4049\/jimmunol.2300319.","journal-title":"J Immunol"},{"key":"9747_CR58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1279846","author":"R Su","year":"2023","unstructured":"Su R, Zhao S, Zhang J, Cao M, Peng S. Metabolic influences on T cell in psoriasis: a literature review. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1279846.","journal-title":"Front Immunol"},{"key":"9747_CR59","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1177\/1535370221993424","volume":"246","author":"Y Gao","year":"2021","unstructured":"Gao Y, Lu J, Bao X, Yi X, Peng C, Chen W, et al. Inhibition of phospholipases suppresses progression of psoriasis through modulation of inflammation. Exp Biol Med. 2021;246:1253\u201362. https:\/\/doi.org\/10.1177\/1535370221993424.","journal-title":"Exp Biol Med"},{"key":"9747_CR60","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.806560","author":"GA Robinson","year":"2022","unstructured":"Robinson GA, Wilkinson M, Wincup C. The role of immunometabolism in the pathogenesis of Systemic Lupus Erythematosus. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2021.806560.","journal-title":"Front Immunol"},{"key":"9747_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1183535","author":"KA Fenton","year":"2023","unstructured":"Fenton KA, Pedersen HL. Advanced methods and novel biomarkers in autoimmune diseases - a review of the recent years progress in systemic lupus erythematosus. Front Med (Lausanne). 2023. https:\/\/doi.org\/10.3389\/fmed.2023.1183535.","journal-title":"Front Med (Lausanne)"},{"key":"9747_CR62","doi-asserted-by":"publisher","DOI":"10.1093\/oxfimm\/iqad005","author":"A Psarras","year":"2023","unstructured":"Psarras A, Clarke A. A cellular overview of immunometabolism in systemic lupus erythematosus. Oxf Open Immunol. 2023. https:\/\/doi.org\/10.1093\/oxfimm\/iqad005.","journal-title":"Oxf Open Immunol"},{"key":"9747_CR63","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.jfma.2021.03.019","volume":"120","author":"H-T Tzeng","year":"2021","unstructured":"Tzeng H-T, Chyuan I-T. Immunometabolism in systemic lupus erythematosus: relevant pathogenetic mechanisms and potential clinical applications. J Formos Med Assoc. 2021;120:1667\u201375. https:\/\/doi.org\/10.1016\/j.jfma.2021.03.019.","journal-title":"J Formos Med Assoc"},{"key":"9747_CR64","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.748573","author":"Z Liu","year":"2021","unstructured":"Liu Z, Le Y, Chen H, Zhu J, Lu D. Role of PKM2-mediated immunometabolic reprogramming on development of cytokine storm. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.748573.","journal-title":"Front Immunol"},{"key":"9747_CR65","doi-asserted-by":"publisher","first-page":"115172","DOI":"10.1016\/j.celrep.2024.115172","volume":"44","author":"JE Toller-Kawahisa","year":"2025","unstructured":"Toller-Kawahisa JE, Viacava PR, Palsson-McDermott EM, Nascimento DC, Cervantes-Silva MP, O\u2019Carroll SM, et al. Metabolic reprogramming of macrophages by PKM2 promotes IL-10 production via adenosine. Cell Rep. 2025;44:115172. https:\/\/doi.org\/10.1016\/j.celrep.2024.115172.","journal-title":"Cell Rep"},{"key":"9747_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41420-025-02453-5","volume":"11","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Wang S-S, Zhang Z, Chu S-F. PKM2-mediated metabolic reprogramming of microglia in neuroinflammation. Cell Death Discov. 2025;11:149. https:\/\/doi.org\/10.1038\/s41420-025-02453-5.","journal-title":"Cell Death Discov"},{"key":"9747_CR67","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.devcel.2022.02.024","volume":"57","author":"J Simcox","year":"2022","unstructured":"Simcox J, Lamming DW. The central motor of metabolism. Dev Cell. 2022;57:691\u2013706. https:\/\/doi.org\/10.1016\/j.devcel.2022.02.024.","journal-title":"Dev Cell"},{"key":"9747_CR68","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1152\/physrev.00026.2020","volume":"101","author":"A Szwed","year":"2021","unstructured":"Szwed A, Kim E, Jacinto E. Regulation and metabolic functions of mTORC1 and mTORC2. Physiol Rev. 2021;101:1371\u2013426. https:\/\/doi.org\/10.1152\/physrev.00026.2020.","journal-title":"Physiol Rev"},{"key":"9747_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13683","volume":"7","author":"M Angela","year":"2016","unstructured":"Angela M, Endo Y, Asou HK, Yamamoto T, Tumes DJ, Tokuyama H, et al. Fatty acid metabolic reprogramming via mTOR-mediated inductions of PPAR\u03b3 directs early activation of T cells. Nat Commun. 2016;7:13683. https:\/\/doi.org\/10.1038\/ncomms13683.","journal-title":"Nat Commun"},{"key":"9747_CR70","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/jleuko\/qiad062","volume":"114","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Gao C, Liu L, Wang L, Song Z. The development and function of human monocyte-derived dendritic cells regulated by metabolic reprogramming. J Leukoc Biol. 2023;114:212\u201322. https:\/\/doi.org\/10.1093\/jleuko\/qiad062.","journal-title":"J Leukoc Biol"},{"key":"9747_CR71","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1172\/JCI84431","volume":"126","author":"SE Corcoran","year":"2016","unstructured":"Corcoran SE, O\u2019Neill LAJ. HIF1\u03b1 and metabolic reprogramming in inflammation. J Clin Invest. 2016;126:3699\u2013707. https:\/\/doi.org\/10.1172\/JCI84431.","journal-title":"J Clin Invest"},{"key":"9747_CR72","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.927329","author":"X Wei","year":"2022","unstructured":"Wei X, Hou Y, Long M, Jiang L, Du Y. Molecular mechanisms underlying the role of hypoxia-inducible factor-1 \u03b1 in metabolic reprogramming in renal fibrosis. Front Endocrinol (Lausanne). 2022. https:\/\/doi.org\/10.3389\/fendo.2022.927329.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9747_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107649","volume":"213","author":"J Zhang","year":"2025","unstructured":"Zhang J, Gao P, Chang W-R, Song J-Y, An F-Y, Wang Y-J, et al. The role of HIF-1\u03b1 in hypoxic metabolic reprogramming in osteoarthritis. Pharmacol Res. 2025;213:107649. https:\/\/doi.org\/10.1016\/j.phrs.2025.107649.","journal-title":"Pharmacol Res"},{"key":"9747_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/ar2568","volume":"11","author":"B Muz","year":"2009","unstructured":"Muz B, Khan MN, Kiriakidis S, Paleolog EM. The role of hypoxia and HIF-dependent signalling events in rheumatoid arthritis. Arthritis Res Ther. 2009;11:201. https:\/\/doi.org\/10.1186\/ar2568.","journal-title":"Arthritis Res Ther"},{"key":"9747_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01177-2","volume":"21","author":"H Chen","year":"2023","unstructured":"Chen H, Deng J, Gao H, Song Y, Zhang Y, Sun J, et al. Involvement of the SIRT1-NLRP3 pathway in the inflammatory response. Cell Commun Signal. 2023;21:185. https:\/\/doi.org\/10.1186\/s12964-023-01177-2.","journal-title":"Cell Commun Signal"},{"key":"9747_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.831168","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, et al. Regulation of SIRT1 and its roles in inflammation. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.831168.","journal-title":"Front Immunol"},{"key":"9747_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1360065","author":"C Ferreira","year":"2024","unstructured":"Ferreira C, Vieira P, S\u00e1 H, Malva J, Castelo-Branco M, Reis F, et al. Polyphenols: immunonutrients tipping the balance of immunometabolism in chronic diseases. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1360065.","journal-title":"Front Immunol"},{"key":"9747_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1465849","author":"H Sun","year":"2024","unstructured":"Sun H, Li D, Wei C, Liu L, Xin Z, Gao H, et al. The relationship between SIRT1 and inflammation: a systematic review and meta-analysis. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1465849.","journal-title":"Front Immunol"},{"key":"9747_CR79","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.871357","author":"L Chen","year":"2022","unstructured":"Chen L, Qin Y, Liu B, Gao M, Li A, Li X, et al. PGC-1\u03b1-mediated mitochondrial quality control: molecular mechanisms and implications for heart failure. Front Cell Dev Biol. 2022. https:\/\/doi.org\/10.3389\/fcell.2022.871357.","journal-title":"Front Cell Dev Biol"},{"key":"9747_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065542","volume":"24","author":"J Peng","year":"2023","unstructured":"Peng J, Yang Z, Li H, Hao B, Cui D, Shang R, et al. Quercetin reprograms immunometabolism of macrophages via the SIRT1\/PGC-1\u03b1 signaling pathway to ameliorate lipopolysaccharide-induced oxidative damage. Int J Mol Sci. 2023;24:5542. https:\/\/doi.org\/10.3390\/ijms24065542.","journal-title":"Int J Mol Sci"},{"key":"9747_CR81","first-page":"3778","volume":"15","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Luo G, Li C, Zhang P, Chen W, Li X, et al. Metformin induces M2 polarization via AMPK\/PGC-1\u03b1\/PPAR-\u03b3 pathway to improve peripheral nerve regeneration. Am J Transl Res. 2023;15:3778\u201392.","journal-title":"Am J Transl Res"},{"key":"9747_CR82","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25052944","volume":"25","author":"P Hartsoe","year":"2024","unstructured":"Hartsoe P, Holguin F, Chu HW. Mitochondrial dysfunction and metabolic reprogramming in obesity and asthma. Int J Mol Sci. 2024;25:2944. https:\/\/doi.org\/10.3390\/ijms25052944.","journal-title":"Int J Mol Sci"},{"key":"9747_CR83","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108650","volume":"24","author":"RW Siggins","year":"2023","unstructured":"Siggins RW, McTernan PM, Simon L, Souza-Smith FM, Molina PE. Mitochondrial dysfunction: at the nexus between alcohol-associated immunometabolic dysregulation and tissue injury. Int J Mol Sci. 2023;24:8650. https:\/\/doi.org\/10.3390\/ijms24108650.","journal-title":"Int J Mol Sci"},{"key":"9747_CR84","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/19768354.2023.2234986","volume":"27","author":"H Jeong","year":"2023","unstructured":"Jeong H, Lee B, Han SJ, Sohn DH. Glucose metabolic reprogramming in autoimmune diseases. Anim Cells Syst (Seoul). 2023;27:149\u201358. https:\/\/doi.org\/10.1080\/19768354.2023.2234986.","journal-title":"Anim Cells Syst (Seoul)"},{"key":"9747_CR85","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41422-020-0291-z","volume":"30","author":"EM P\u00e5lsson-McDermott","year":"2020","unstructured":"P\u00e5lsson-McDermott EM, O\u2019Neill LAJ. Targeting immunometabolism as an anti-inflammatory strategy. Cell Res. 2020;30:300\u201314. https:\/\/doi.org\/10.1038\/s41422-020-0291-z.","journal-title":"Cell Res"},{"key":"9747_CR86","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12016-020-08821-6","volume":"60","author":"T Wang","year":"2021","unstructured":"Wang T, Jiao Y, Zhang X. Immunometabolic pathways and its therapeutic implication in autoimmune diseases. Clin Rev Allergy Immunol. 2021;60:55\u201367. https:\/\/doi.org\/10.1007\/s12016-020-08821-6.","journal-title":"Clin Rev Allergy Immunol"},{"key":"9747_CR87","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3904\/kjim.2021.363","volume":"37","author":"J-W Kim","year":"2022","unstructured":"Kim J-W, Choe J-Y, Park S-H. Metformin and its therapeutic applications in autoimmune inflammatory rheumatic disease. Korean J Intern Med. 2022;37:13\u201326. https:\/\/doi.org\/10.3904\/kjim.2021.363.","journal-title":"Korean J Intern Med"},{"key":"9747_CR88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01236","author":"F Ursini","year":"2018","unstructured":"Ursini F, Russo E, Pellino G, D\u2019Angelo S, Chiaravalloti A, De Sarro G, et al. Metformin and autoimmunity: a \u201cnew deal\u201d of an old drug. Front Immunol. 2018. https:\/\/doi.org\/10.3389\/fimmu.2018.01236.","journal-title":"Front Immunol"},{"key":"9747_CR89","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.exphem.2020.08.001","volume":"89","author":"H Li","year":"2020","unstructured":"Li H, Ji J, Du Y, Huang Y, Gu H, Chen M, et al. Sirolimus is effective for primary relapsed\/refractory autoimmune cytopenia: a multicenter study. Exp Hematol. 2020;89:87\u201395. https:\/\/doi.org\/10.1016\/j.exphem.2020.08.001.","journal-title":"Exp Hematol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-026-09747-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-026-09747-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T07:47:28Z","timestamp":1770450448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-026-09747-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,7]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9747"],"URL":"https:\/\/doi.org\/10.1007\/s12026-026-09747-5","relation":{},"ISSN":["1559-0755"],"issn-type":[{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,7]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"11"}}